BR0014877A - Veìculo magnético objetivado composto de ferro e materiais porosos para a distribuição objetivada de agentes biologicamente ativos - Google Patents

Veìculo magnético objetivado composto de ferro e materiais porosos para a distribuição objetivada de agentes biologicamente ativos

Info

Publication number
BR0014877A
BR0014877A BR0014877-6A BR0014877A BR0014877A BR 0014877 A BR0014877 A BR 0014877A BR 0014877 A BR0014877 A BR 0014877A BR 0014877 A BR0014877 A BR 0014877A
Authority
BR
Brazil
Prior art keywords
iron
biologically active
active agents
porous materials
vehicle composed
Prior art date
Application number
BR0014877-6A
Other languages
English (en)
Portuguese (pt)
Inventor
Scott Raymond Rudge
Terri Lynn Kurtz
Gilles Hugues Tapolsky
Yuhua Li
Original Assignee
Ferx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferx Inc filed Critical Ferx Inc
Publication of BR0014877A publication Critical patent/BR0014877A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6923—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ceramic Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Paints Or Removers (AREA)
BR0014877-6A 1999-10-18 2000-10-13 Veìculo magnético objetivado composto de ferro e materiais porosos para a distribuição objetivada de agentes biologicamente ativos BR0014877A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16029399P 1999-10-18 1999-10-18
PCT/US2000/028615 WO2001028587A2 (en) 1999-10-18 2000-10-13 Magnetic targeted carrier

Publications (1)

Publication Number Publication Date
BR0014877A true BR0014877A (pt) 2002-06-11

Family

ID=22576298

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0014877-6A BR0014877A (pt) 1999-10-18 2000-10-13 Veìculo magnético objetivado composto de ferro e materiais porosos para a distribuição objetivada de agentes biologicamente ativos

Country Status (15)

Country Link
EP (1) EP1221974A2 (zh)
JP (3) JP2003512336A (zh)
KR (1) KR20020064299A (zh)
CN (1) CN1287859C (zh)
AU (1) AU772755B2 (zh)
BR (1) BR0014877A (zh)
CA (1) CA2387925A1 (zh)
CZ (1) CZ293919B6 (zh)
DE (1) DE1221974T1 (zh)
ES (1) ES2182731T1 (zh)
HK (1) HK1045110A1 (zh)
IL (1) IL149004A0 (zh)
MX (1) MXPA02003891A (zh)
NZ (1) NZ518311A (zh)
WO (1) WO2001028587A2 (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9808052D0 (en) 1998-04-17 1998-06-17 Secr Defence Implants for administering substances and methods of producing implants
EP1668424A4 (en) * 2003-09-12 2009-11-25 Onkor Pharmaceuticals Inc MAGNETICALLY DETERMINABLE PARTICLES WITH MAGNETIC COMPONENTS AND BIOCOMPATIBLE POLYMERS FOR THE LOCAL DELIVERY OF BIOLOGICALLY ACTIVE ACTIVE SUBSTANCES
JP2007001865A (ja) * 2003-09-16 2007-01-11 Ltt Bio-Pharma Co Ltd 脂溶性薬物封入微粒子、その製造法およびそれを含有する製剤
JP4982084B2 (ja) * 2004-02-09 2012-07-25 株式会社サンギ 抗腫瘍剤
WO2005079867A2 (en) * 2004-02-20 2005-09-01 Algeta As Alpha-emitting hydroxyapatite particles
GB0403856D0 (en) * 2004-02-20 2004-03-24 Algeta As Composition
JP2006199810A (ja) * 2005-01-20 2006-08-03 Yokohama National Univ 複合粒子およびその製造方法
US8293274B2 (en) 2005-04-06 2012-10-23 Kabushiki Kaisha Sangi Intestinal absorptive anti-tumor agent
CA2758607C (en) 2009-05-04 2018-05-15 Psivida Us, Inc. Porous silicon drug-eluting particles
US9333173B2 (en) 2010-11-01 2016-05-10 Psivida Us, Inc. Bioerodible silicon-based devices for delivery of therapeutic agents
JP6170154B2 (ja) * 2012-08-28 2017-07-26 バイオキューブシステム インコーポレイテッド 生物学的試料から核酸増幅反応用生物学的分子を迅速に分離するための多孔性固体相及びその用途
CA2904077A1 (en) 2013-03-15 2014-09-25 Psivida Us, Inc. Bioerodible silicon-based compositions for delivery of therapeutic agents
JP6443907B2 (ja) * 2014-02-17 2018-12-26 浩文 山本 造影剤の腫瘍への集積を促進するための集積促進剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4243652A (en) * 1978-07-14 1981-01-06 The Procter & Gamble Company Gastrointestinal scanning agent
ES2066851T3 (es) * 1988-05-24 1995-03-16 Anagen Uk Ltd Particulas atraibles magneticamente y metodo de preparacion.
DE59508069D1 (de) * 1994-07-27 2000-04-27 Herbert Pilgrimm Superparamagnetische teilchen, verfahren zur herstellung und deren verwendung
WO1997001304A1 (en) * 1995-06-29 1997-01-16 Mallinckrodt Medical, Inc. Radiolabeled apatite particles containing a paramagnetic ion
JP3735990B2 (ja) * 1997-01-28 2006-01-18 東ソー株式会社 磁性シリカゲルの製造方法

Also Published As

Publication number Publication date
CA2387925A1 (en) 2001-04-26
DE1221974T1 (de) 2003-02-06
AU772755B2 (en) 2004-05-06
EP1221974A2 (en) 2002-07-17
MXPA02003891A (es) 2002-12-09
JP2003321348A (ja) 2003-11-11
WO2001028587A2 (en) 2001-04-26
JP2005200426A (ja) 2005-07-28
AU1090501A (en) 2001-04-30
KR20020064299A (ko) 2002-08-07
CZ20021357A3 (cs) 2002-11-13
CZ293919B6 (cs) 2004-08-18
JP2003512336A (ja) 2003-04-02
WO2001028587A3 (en) 2002-01-03
CN1420787A (zh) 2003-05-28
IL149004A0 (en) 2002-11-10
CN1287859C (zh) 2006-12-06
HK1045110A1 (zh) 2002-11-15
ES2182731T1 (es) 2003-03-16
NZ518311A (en) 2003-10-31

Similar Documents

Publication Publication Date Title
BR0014877A (pt) Veìculo magnético objetivado composto de ferro e materiais porosos para a distribuição objetivada de agentes biologicamente ativos
DE3872741T (zh)
DE69531741D1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe
BR9906786A (pt) Composição magneticamente responsiva
ATE337019T1 (de) Geladene lipide und deren verwendung
DE69433818D1 (de) Kombinierte wirkstoffe als methode zur gezielten wirkstoff-freisetzung
ES2130217T3 (es) Uso de tiloxapol como dispersante y estabilizante de nanoparticulas.
EP1982732A3 (en) Factor VII or VIIA-like conjugates
EP1992643A3 (en) Compositions and methods for the diagnosis and treatment of tumor
IL112664A (en) 4-amino derivatives of mycophenolic acid their preparation and pharmaceutical compositions containing them
ATE355288T1 (de) Verbindungen und therapeutische methoden
IT1264690B1 (it) Compositi oligomeri iodurati e composizioni diagnostiche contenenti gli stessi
WO1999043636A3 (en) Disubstituted lavendustin a analogs and pharmaceutical compositions comprising the analogs
CA2449856A1 (en) Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells
Gao et al. Protease-loaded CuS nanoparticles with synergistic Photothermal/dynamic therapy against F. nucleatum-induced periodontitis
DE69906064D1 (de) Glycoproteine mit lipidmobilisierenden eigenschaften und deren therapeutische verwendungen
DE69223504D1 (de) Bicycloazamakrocyclophosphon-Säure, Komplexe, Konjugate, Kontrastmittel und Herstellung
IL59938A (en) 6-substituted 11-alkylene-morphanthridines,their preparation and pharmaceutical compositions containing them
ATE249243T1 (de) Biotinylierter antikörper mit verminderter positiver nettoladung und toxin, medikament oder chelat
IL112666A (en) 4-Amino derivatives of 5-substituted mycophenolic acid their preparation and pharmaceutical compositions containing them
WO2007042833A3 (en) Arnphiphilic nanotubes and micelles comprising same for use in the delivery of biologically active agents
BR0005318A (pt) Utilização de inibidores de secreção da apo b/mtp e agentes antiobesidade
TNSN03024A1 (fr) Composition sous forme d'emulsion appropriee pour le traitement de l'hyperhidrose et/ou bromhidrose plantaire
IT1252160B (it) Composizioni farmaceutiche contenenti il peptidoglicano del lactobacillus casei
Mallya Nanomaterials and Nanotechnology in Conservative Dentistry and Endodontics.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2008 DE 30/06/2009.